<DOC>
	<DOC>NCT00772369</DOC>
	<brief_summary>The purpose of this survey is to collect selected safety data. Primary Objective: To collect selected safety data at 6 months following the 4th dose of the Pentacel® series.</brief_summary>
	<brief_title>Retrospective Survey of Safety of Fourth Dose Pentacel® in Children</brief_title>
	<detailed_description>This is a retrospective survey to collect selected safety data at 6 months following the 4th dose of Pentacel® in children residing in the Canadian Province of British Columbia who have received the 4th dose of the Pentacel® series before their 2nd birthday.</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<criteria>Children residing in the Canadian Province of British Columbia who have received the 4th dose of the Pentacel® series before their 2nd birthday. Written Informed Consent and Telephone consent from the parent(s) or guardian(s). Able to comply with the survey procedures. Fourth dose of the Pentacel® series received on or after the child's 2nd birthday.</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Pertussis</keyword>
	<keyword>Whooping cough</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Haemophilus influenzae</keyword>
	<keyword>Poliovirus Types 1, 2, and 3.</keyword>
</DOC>